Philip D Harvey1, Mihaela Aslan2, Mengtian Du3, Hongyu Zhao2, Larry J Siever4, Ann Pulver5, J Michael Gaziano6, John Concato2. 1. Department of Research Service, Bruce W. Carter Miami Veterans Affairs Medical Center. 2. Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System. 3. Department of Statistics, Yale Graduate School of Arts and Sciences, Yale University. 4. Department of Psychiatry Service, James J. Peters Veterans Affairs Medical Center. 5. Department of Epidemiology, Bloomberg School of Public Health. 6. Massachusetts Veteran Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System.
Abstract
OBJECTIVE: Impairments in cognition and everyday functioning are common in schizophrenia and bipolar disorder (BPD). In this article, we present factor analyses of cognitive and functional capacity (FC) measures based on 2 studies of schizophrenia (SCZ) and bipolar I disorder (BPI) using similar methods. The overall goal of these analyses was to determine whether performance-based assessments should be examined individually, or aggregated on the basis of the correlational structure of the tests, as well as to evaluate the similarity of factor structures of SCZ and BPI. METHOD: Veterans Affairs Cooperative Studies Program Study #572 (Harvey et al., 2014) evaluated cognitive and FC measures among 5,414 BPI and 3,942 SCZ patients. A 2nd study evaluated similar neuropsychological (NP) and FC measures among 368 BPI and 436 SCZ patients. Principal components analysis, as well as exploratory and CFAs, were used to examine the data. RESULTS: Analyses in both datasets suggested that NP and FC measures were explained by a single underlying factor in BPI and SCZ patients, both when analyzed separately or as in a combined sample. The factor structure in both studies was similar, with or without inclusion of FC measures; homogeneous loadings were observed for that single factor across cognitive and FC domains across the samples. CONCLUSION: The empirically derived factor model suggests that NP performance and FC are best explained as a single latent trait applicable to people with SCZ and BPD. This single measure may enhance the robustness of the analyses relating genomic data to performance-based phenotypes. (c) 2015 APA, all rights reserved).
OBJECTIVE: Impairments in cognition and everyday functioning are common in schizophrenia and bipolar disorder (BPD). In this article, we present factor analyses of cognitive and functional capacity (FC) measures based on 2 studies of schizophrenia (SCZ) and bipolar I disorder (BPI) using similar methods. The overall goal of these analyses was to determine whether performance-based assessments should be examined individually, or aggregated on the basis of the correlational structure of the tests, as well as to evaluate the similarity of factor structures of SCZ and BPI. METHOD: Veterans Affairs Cooperative Studies Program Study #572 (Harvey et al., 2014) evaluated cognitive and FC measures among 5,414 BPI and 3,942 SCZ patients. A 2nd study evaluated similar neuropsychological (NP) and FC measures among 368 BPI and 436 SCZ patients. Principal components analysis, as well as exploratory and CFAs, were used to examine the data. RESULTS: Analyses in both datasets suggested that NP and FC measures were explained by a single underlying factor in BPI and SCZ patients, both when analyzed separately or as in a combined sample. The factor structure in both studies was similar, with or without inclusion of FC measures; homogeneous loadings were observed for that single factor across cognitive and FC domains across the samples. CONCLUSION: The empirically derived factor model suggests that NP performance and FC are best explained as a single latent trait applicable to people with SCZ and BPD. This single measure may enhance the robustness of the analyses relating genomic data to performance-based phenotypes. (c) 2015 APA, all rights reserved).
Authors: Julie Akiko Gladsjo; Lou Ann McAdams; Barton W Palmer; David J Moore; Dilip V Jeste; Robert K Heaton Journal: Schizophr Bull Date: 2004 Impact factor: 9.306
Authors: Philip D Harvey; Margaret M McClure; Thomas L Patterson; John A McGrath; Ann E Pulver; Christopher R Bowie; Larry J Siever Journal: Schizophr Bull Date: 2011-05-11 Impact factor: 9.306
Authors: Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman Journal: Neuropsychopharmacology Date: 2006-04-19 Impact factor: 7.853
Authors: Brent T Mausbach; Philip D Harvey; Ann E Pulver; Colin A Depp; Paula S Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Christopher R Bowie; Thomas L Patterson Journal: Bipolar Disord Date: 2010-02 Impact factor: 6.744
Authors: Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum Journal: Schizophr Res Date: 2012-04-13 Impact factor: 4.939
Authors: Philip D Harvey; Larry J Siever; Grant D Huang; Sumitra Muralidhar; Hongyu Zhao; Perry Miller; Mihaela Aslan; Shrikant Mane; Margaret McNamara; Theresa Gleason; Mary Brophy; Ronald Przygodszki; Timothy J O'Leary; Michael Gaziano; John Concato Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2014-05-05 Impact factor: 3.568
Authors: Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson Journal: J Int Neuropsychol Soc Date: 2013-02-21 Impact factor: 2.892
Authors: Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport Journal: Schizophr Res Date: 2017-11-13 Impact factor: 4.939
Authors: Saba Shahab; Benoit H Mulsant; Melissa L Levesque; Navona Calarco; Arash Nazeri; Anne L Wheeler; George Foussias; Tarek K Rajji; Aristotle N Voineskos Journal: Neuropsychopharmacology Date: 2018-12-20 Impact factor: 7.853
Authors: Philip D Harvey; William P Horan; Alexandra S Atkins; Heather Stevens; Matthew Welch; Joshua Yuan; Thomas L Patterson; Meera Narasimhan; Richard S E Keefe Journal: Schizophr Res Date: 2020-09-11 Impact factor: 4.939
Authors: Martin T Strassnig; Michelle L Miller; Raeanne Moore; Colin A Depp; Amy E Pinkham; Philip D Harvey Journal: Psychiatry Res Date: 2021-04-04 Impact factor: 11.225
Authors: Philip D Harvey; Daniela Bolivar Forero; Lauren B Ahern; Lize Tibiriçá; Peter Kallestrup; Sara J Czaja Journal: Am J Geriatr Psychiatry Date: 2020-09-07 Impact factor: 4.105
Authors: Philip D Harvey; Tim B Bigdeli; Ayman H Fanous; Yuli Li; Nallakkandi Rajeevan; Frederick Sayward; Krishnan Radhakrishnan; Grant Huang; Mihaela Aslan Journal: Pers Med Psychiatry Date: 2021-07
Authors: James A Karantonis; Sean P Carruthers; Susan L Rossell; Christos Pantelis; Matthew Hughes; Cassandra Wannan; Vanessa Cropley; Tamsyn E Van Rheenen Journal: Schizophr Bull Date: 2021-10-21 Impact factor: 7.348